Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2002;39:508-512
doi: 10.1161/hy02t2.102907
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Motley, E. D.
Right arrow Articles by Eguchi, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Motley, E. D.
Right arrow Articles by Eguchi, S.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Cell signalling/signal transduction
Right arrow Mechanism of atherosclerosis/growth factors

(Hypertension. 2002;39:508.)
© 2002 American Heart Association, Inc.


Scientific Contributions

Lysophosphatidylcholine Inhibits Insulin-Induced Akt Activation Through Protein Kinase C-{alpha} in Vascular Smooth Muscle Cells

Evangeline D. Motley; Syeda M. Kabir; Carla D. Gardner; Kunie Eguchi; Gerald D. Frank; Toshio Kuroki; Motoi Ohba; Tadashi Yamakawa; Satoru Eguchi

From the Department of Anatomy and Physiology (E.D.M., S.M.K., C.D.G., K.E.), Meharry Medical College, and the Department of Biochemistry (G.D.F., S.E.), Vanderbilt University School of Medicine, Nashville, Tenn; the Institute of Molecular Oncology (T.K., M.O.), Showa University, Tokyo, Japan; and the Department of Endocrinology and Diabetes (T.Y.), Yokohama City University Medical Center, Yokohama, Japan.

Correspondence to Evangeline D. Motley, PhD, Department of Anatomy and Physiology, Meharry Medical College, 1005 D.B. Todd Blvd, Nashville, TN 37208. E-mail emotley{at}mmc.edu

Abstract— To better understand the intracellular signaling mechanism that causes the association of insulin resistance and hyperlipidemia with cardiovascular diseases, we specifically looked at the ability of lysophosphatidylcholine (lysoPC) to inhibit the Akt activation induced by insulin in cultured rat aortic vascular smooth muscle cells. LysoPC inhibited the insulin-induced phosphorylation of Akt at Ser473, and the inhibition was concentration dependent. Phorbol 12-myristate 13-acetate (PMA), a protein kinase C (PKC) activator, inhibited the insulin-induced phosphorylation of Akt. LysoPC stimulated PKC phosphorylation at Ser660, which was inhibited by the PKC inhibitor GF109203X. The PKC-{alpha}/ß-selective inhibitor Go6976 also blocked the PMA- and lysoPC-induced inhibition of Akt phosphorylation by insulin. PKC-{alpha}, but not PKC-ß, is expressed in vascular smooth muscle cells, and overexpression of PKC-{alpha}, but not PKC-ß or PKC-{delta}, inhibited insulin-induced Akt activation. LysoPC rapidly stimulated PKC-{alpha} translocation to the membrane. In contrast, pretreatment with the p42/44 mitogen-activated protein kinase kinase inhibitor PD98059 or the p38 mitogen-activated protein kinase inhibitor SB203580 did not block the lysoPC-induced inhibition of Akt phosphorylation by insulin. In addition, lysoPC inhibited the insulin-induced tyrosine phosphorylation of insulin receptor substrate (IRS)-1 but not that of the insulin receptor ß subunit or insulin binding. PMA treatment or PKC-{alpha} overexpression also inhibited the tyrosine phosphorylation of IRS-1. From these data, we conclude that lysoPC negatively regulates the insulin signal at the point of IRS-1 through PKC-{alpha} in the vasculature, which may explain the association of hyperlipidemia with hyperinsulinemia in cardiovascular diseases.


Key Words: lysophosphatidylcholines • insulin resistance • muscle, smooth, vascular • protein kinases




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
L. Cheng, X. Han, and Y. Shi
A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice
Am J Physiol Endocrinol Metab, December 1, 2009; 297(6): E1276 - E1282.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Guan, K. Song, M. A. Pysz, K. J. Curry, A. A. Hizli, D. Danielpour, A. R. Black, and J. D. Black
Protein Kinase C-mediated Down-regulation of Cyclin D1 Involves Activation of the Translational Repressor 4E-BP1 via a Phosphoinositide 3-Kinase/Akt-independent, Protein Phosphatase 2A-dependent Mechanism in Intestinal Epithelial Cells
J. Biol. Chem., May 11, 2007; 282(19): 14213 - 14225.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. Clavreul, M. M. Bachschmid, X. Hou, C. Shi, A. Idrizovic, Y. Ido, D. Pimentel, and R. A. Cohen
S-Glutathiolation of p21ras by Peroxynitrite Mediates Endothelial Insulin Resistance Caused by Oxidized Low-Density Lipoprotein
Arterioscler Thromb Vasc Biol, November 1, 2006; 26(11): 2454 - 2461.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. Namgaladze and B. Brune
Phospholipase A2-Modified Low-Density Lipoprotein Activates the Phosphatidylinositol 3-Kinase-Akt Pathway and Increases Cell Survival in Monocytic Cells
Arterioscler Thromb Vasc Biol, November 1, 2006; 26(11): 2510 - 2516.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
J. Mookerjee Basu, A. Mookerjee, P. Sen, S. Bhaumik, P. Sen, S. Banerjee, K. Naskar, S. K. Choudhuri, B. Saha, S. Raha, et al.
Sodium Antimony Gluconate Induces Generation of Reactive Oxygen Species and Nitric Oxide via Phosphoinositide 3-Kinase and Mitogen-Activated Protein Kinase Activation in Leishmania donovani-Infected Macrophages.
Antimicrob. Agents Chemother., May 1, 2006; 50(5): 1788 - 1797.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
E. D. Labonte, R. J. Kirby, N. M. Schildmeyer, A. M. Cannon, K. W. Huggins, and D. Y. Hui
Group 1B Phospholipase A2-Mediated Lysophospholipid Absorption Directly Contributes to Postprandial Hyperglycemia.
Diabetes, April 1, 2006; 55(4): 935 - 941.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. Rask-Madsen and G. L. King
Proatherosclerotic Mechanisms Involving Protein Kinase C in Diabetes and Insulin Resistance
Arterioscler Thromb Vasc Biol, March 1, 2005; 25(3): 487 - 496.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
W. Takabe, Y. Kanai, A. Chairoungdua, N. Shibata, S. Toi, M. Kobayashi, T. Kodama, and N. Noguchi
Lysophosphatidylcholine Enhances Cytokine Production of Endothelial Cells via Induction of L-Type Amino Acid Transporter 1 and Cell Surface Antigen 4F2
Arterioscler Thromb Vasc Biol, September 1, 2004; 24(9): 1640 - 1645.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Tanaka, M. V. Gavrielides, Y. Mitsuuchi, T. Fujii, and M. G. Kazanietz
Protein Kinase C Promotes Apoptosis in LNCaP Prostate Cancer Cells through Activation of p38 MAPK and Inhibition of the Akt Survival Pathway
J. Biol. Chem., September 5, 2003; 278(36): 33753 - 33762.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
C. D. Gardner, S. Eguchi, C. M. Reynolds, K. Eguchi, G. D. Frank, and E. D. Motley
Hydrogen Peroxide Inhibits Insulin Signaling in Vascular Smooth Muscle Cells
Experimental Biology and Medicine, July 1, 2003; 228(7): 836 - 842.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
E. D. Motley, K. Eguchi, C. Gardner, A. L. Hicks, C. M. Reynolds, G. D. Frank, M. Mifune, M. Ohba, and S. Eguchi
Insulin-Induced Akt Activation Is Inhibited by Angiotensin II in the Vasculature Through Protein Kinase C-{alpha}
Hypertension, March 1, 2003; 41(3): 775 - 780.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Saito, G. D. Frank, M. Mifune, M. Ohba, H. Utsunomiya, E. D. Motley, T. Inagami, and S. Eguchi
Ligand-independent trans-Activation of the Platelet-derived Growth Factor Receptor by Reactive Oxygen Species Requires Protein Kinase C-delta and c-Src
J. Biol. Chem., November 15, 2002; 277(47): 44695 - 44700.
[Abstract] [Full Text] [PDF]